Vycor Medical, Inc. (VYCO)

OTCMKTS · Delayed Price · Currency is USD

0.0660

+0.0090 (15.79%)

Jun 17, 2026, 4:00 PM EST

-42.61% (1Y)

Market Cap	2.20M -40.0%
Revenue (ttm)	1.89M +11.7%
Net Income	-338.13K
EPS	-0.01
Shares Out	33.37M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,900
Open	0.0660
Previous Close	0.0570
Day's Range	0.0570 - 0.0660
52-Week Range	0.0321 - 0.2000
Beta	-0.53
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 12, 2026

About Vycor Medical

Vycor Medical, Inc. designs, develops, and markets neurological medical devices and therapies in the United States and Europe. The company operates through two segments: Vycor Medical and NovaVision. Its Vycor Medical segment provides devices for neurosurgery comprising ViewSite Brain Access System, a retraction and access system for brain and spine surgeries. The NovaVision segment offers non-invasive computer-based rehabilitation therapies targeted at people who have impaired vision as a result of stroke or other brain injury. It has a licens... [Read more]

Industry Medical Devices

Sector Healthcare

Founded 2005

Employees 7

Stock Exchange OTCMKTS

Ticker Symbol VYCO

Full Company Profile

Financial Performance

In 2025, Vycor Medical's revenue was $1.86 million, an increase of 17.24% compared to the previous year's $1.59 million. Losses were -$396,796, -8.06% less than in 2024.

Financial Statements